Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Corcept Therapeutics (CORT)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for CORT as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
173K
VERY LOW
EBITDA
►
-21.2M
AVG
Net Income
►
-21.2M
AVG
Revenue Growth
►
162.1%
HIGH
Operating Margin
►
-12028.9%
VERY LOW
Net Margin
►
-12235.3%
VERY LOW
Revenue, Gross Profit, and Gross Margin
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.255
AVG
Current Ratio
►
4.84
AVG
Quick Ratio
►
4.84
AVG
Book Value Per Share
►
0.136
Cash Per Share
►
0.157
Loading...
STOCK SUMMARY
Open
2.02
Day Range
2.07
-
2.20
52 Week Range
0.73
-
3.10
Volume
18K
Avg Volume (3 mo)
58K
Shares Outstanding
50.0M
Market Cap
104M
VALUATION
Price to Earnings (P/E)
►
-6.64
Price to Book (P/B)
►
15.2
AVG
Price to Sales (P/S)
►
813
VERY HIGH
Return on Assets (ROA)
►
-116.6%
AVG
Return on Equity (ROE)
►
-138%
AVG
EV/EBITDA
►
-7.15
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
16.7%
Net Insider Buying 6mo
16.7%
Net Insider Buying 1yr
4.5%
Held by insiders
112.1%
Held by institutions
3.9%
No Sales Breakout Data.